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Abstract 
Majchrzak, Mark J. and Steven C. Dilsaver: Chronic Treatment with 
Ethanol Produces Supersensitivity to Oxotremorine. Prog. Neuro- 
Psychopharmacol. & Biol. Psychol., 1990, &&:379-386 
1. The effect of chronic treatment with ethanol (14% v:v in drinking 
water) on the physiological endpoint core temperature which is 
partially regulated by a muscarinic mechanism was measured in 
adult male rats (n = 8). 
2. One and two weeks of treatment were associated with enhancement 
of the hypothermic response to oxotremorine, 0.25 mg/kg ip (p = 
0.0005 and p = 0.0001, respectively). 
3. The sample remained supersensitive to this muscarinic agonist 48 
and 96 hours after the discontinuation of treatment (p = 0.0014 
and p = 0.013 respectively). 
4. Repeated injections of oxotremorine, 0.25 mgfkg ip, every other 
day for 10 days did not produce carry-over effects in a control 
experiment. 
5. The results suggest that ethanol renders muscarinic mechanisms 
supersensitive during chronic treatment and that supersensitivity 
remains up to 96 hours following withdrawal. 
Kevwords: acetylcholine, alcohol, cholinergic, ethanol, muscarinic 
receptors, thermoregulation 
Abbreviations: acetylcholine (Ach), intraperitoneally (ip), minutes 
(min), muscarinic acetylcholine receptor (mAchR), oxotremorine (0X0), 
[3H]-~inuclidynl benzilate (QNB) 
Introduction 
Many non-psychedelic substances of abuse directly block the access 
of acetylcholine to the post-synaptic muscarinic acetylcholine 
receptor (mAchR) or inhibit the release of this neurotransmitter from 
presynaptic neurons. Drugs with these properties include classical 
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antimuscarinic agents, opiates, barbiturates, tetrahydrocannabinol, 
and ethanol (Dilsaver, 1986; Dilsaver, 1987). Ethanol decreases the 
release of Ach in various brain regions both in vivo and in vitro 
(Carmichael and Israel, 1975; Erikson and Graham, 1973; Hunt and 
Dalton, 1976). It might therefore partially denervate post-synaptic 
mAchRs thus supersensitizing muscarinic cholinergic networks. The 
authors tested this hypothesis by studying the capacity of orally 
administered ethanol to alter the hypothermic response to the 
muscarinic agonist oxotremorine. 
Material and Methods 
Animals 
Adult, male Sprague-Dawley rats were purchased from Harlan 
Laboratories (Iendianapolis, IN, U.S.A.). The animals were housed in 
groups of 4 during treatment and were allowed food and water 
containing ethanol. The animals were placed in individual cages 16 
hours prior to oxotremorine challenges. 
A control experiment was conducted to demonstrate that multiple 
injections of oxotremorine (0.15 mg/kg) does not produce tolerance. 
Pharmaceutical Aaents 
Oxotremorine (base) and methylscopolamine nitrate were purchased 
from Sigma Chemical Company (St. Louis, MO). 
Druas 
Administration of Ethanol: Ethanol was administered by its addition 
to water (14% by volume). This was the sole drinking fluid. 
Oxotremorine Challenae: Each oxotremorine challenge was conducted 
between 0930 and 1200 hours and was preceded by the administration of 
methylscopolamine nitrate, 1.0 mg/kg ip by 30 minutes, to block the 
peripheral effects of oxotremorine. Baseline temperature was measured 
30 minutes later. This dose of methylscopolamine does not alter core 
temperature 30 minutes after its administration (Dilsaver, 1987). 
Oxotremorine (base) 0.25 mg/kg ip, was administered following the 
baseline measurement of core temperature. Temperature was then 
recorded every 10 minutes for 120 minutes. 
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Temoerature Measurement 
Thermosensors (Mini-Mitter Corp., Sun River, OR) were implanted into 
the peritoneal cavity of 8 adult, male Sprague-Dawley rats weighing 
206.9 + SEM. These devices emit radio waves at a rate proportional 
to core temperature. A transistor radio set to an AM frequency served 
as a receiver. Time to emit 10 sounds was measured using a digital 
display stopwatch. This measure was converted to temperature using 
a linear regression equation, which was derived by measuring the 
emission rate of the thermosensors at three temperatures in a 
temperature-controlled water bath. This instrument allows the 
accurate detection of a change in temperature of O.l'C. Details 
regarding the calibration and use of the thermosensor are available 
elsewhere (Dilsaver et al, in press: Gallaher and Egner, 1987; Tocco- 
Bradley et al., 1985). Principles governing the use of measurements 
of core temperature in psychopharmacological research were the topic 
of a recent review (Dilsaver and Alessi, 1988). 
The thermic response to oxotremorine was measured at baseline, i.e., 
prior to the administration of ethanol, and at one-week intervals 
after that for two weeks. The thermic response to oxotremorine was 
also measured 48 and 96 hours after the discontinuation of treatment 
of ethanol. Significance of the hypothermic response to oxotremorine 
for a given challenge was determined by analysis of variance (AROVA) 
with repeated measures. All measures of variance in the text refer 
to the standard error of the mean (SEM). 
Results 
Mean core temperature prior to the first (baseline) challenge with 
oxotremorine was 38.2 + 0.3'C. The mean core temperature for the 120- 
min period following the first challenge with oxotremorine was 38.1 
+ 0.2'C (ns). Treatment with ethanol for 7 days produced a mean 
hypothermic response of 0.47 + D.ll'C and a highly significant 
enhancement of the hypothermic response as a function of time relative 
to baseline (p = 0.0005, f = 3.36, df = 12/84). Fourteen days of 
treatment with ethanol resulted in further enhancement of the 
hypothermic response to 0.59 + 0.09OC. Further, the change in mean 
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hypothermic response as a function of time was highly significant (p 
< 0.0001, f = 4.45, df = 12/84)(Table 1). 
The mean hypothermic response after 48 hours of abstinence was 0.47 
+ O.llOC. The hypothermic response as a function of time relative to 
baseline was significant (p = 0.0014, f = 3.03, df = 12/84). The 
hypothermic response after 96 hours of abstinence was 0.54 + 0.7'C and 
the thermic response as a function of time remained enhanced (p = 
0.013, f = 2.31, df = 12/84) (Figl). 
The average weight of the animals during the period of ethanol 
administration increased by an average of 29 + 5.2 g per week. The 
animals remained healthy throughout the study. 
Table 1 
Summary of Findings and Statistical Analysis 
Mean Core Temverature: 
Before treatment with ethanol 
Hvvothermic Resvonse 
38.2 + 0.3'C 
After first challenge with oxotremorine: -0.1 2 O.l°C 
Following 7 days of treatment with ethanol: -0.47 + O.ll°C 
Following 14 days of treatment with ethanol: -0.59 + O.llY 
Sisnificance of hvvothermic resvonse as a function of time: 
(two-way ANOVA for repeated measures) 
After first challenge with oxotremorine not significant 
Following 7 days of treatment p=O.O005, F=3.36, df=12/84 
Following 14 days of treatment p<O.O001, F=4.45, df=12/84 
Exveriment 2 (Control Exveriment), 
The hypothesis subjected to testing in the main experiment is that 
"chronic treatment with ethanol will render animals supersensitive to 
the hypothermic effects of a muscarinic agonist." The experimental 
design required multiple injections of oxotremorine, 0.25 mg/kg ip. 
This raises the possibility of carry-over effects. Repeated 
injections of cholinomimetic agents could produce subsensitivity to 
subsequent challenges (Dilsaver, 1986; Marks and Collins, 1985; 
Overstreet, et al, 1973). We challenged animals (n = 8, mean weight 
+ SEM = 304.7 + 5.2) with oxotremorine, 0.25 mg/kg ip, every other day 
for 10 days. Each of the 5 challenges was preceded by the injection 
of methylscopolamine nitrate, 1.0 mg/kg ip, by 30 minutes. The mean 
hypothermic response on Day 1 was 0.28 + O.ll°C. The mean response as 
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a function of time did not differ across time, i.e., between 
challenges 1 (p = 0.50, F = 0.96, df = 12/84), 3 (p = 0.34, f = 1.13, 
df = 12/84), and 5 (p = 0.66, f = 0.79, df = 12/84). Thus, there was 
no detectible change in the thermic responsiveness to oxotremorine. 
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Fig 1. This illustrates the ethanol-induced increase in the mean 
hypothermic response of the experimental group (n=8) to the muscarinic 
cholinergic agonist OX0 (0.25 mg/kg ip) relative to baseline after 7 
and 14 days of treatment (14% by volume) and after 48 and 96 hours of 
abstinence. Methylscopolamine nitrate (1 mg/kg ip) was administered 
30 min before 0X0. Core temperature was measured every 10 min for 120 
min following the injection of 0X0. The mean hypothermic response of 
a given rat is the average of the 12 deviations from the animal's core 
temperature at t=O. The mean hypothermic response of the group to 0x0 
was significantly elevated at all four points depicted in this 
illustration. Please see the results section for the results of an 
analysis of hypothermic response as a function of time. 
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Discussioq 
m io 
Drugs which inhibit the release of Ach indirectly denervate post- 
synaptic IllAChRS and should therefore affect lUAChR receptor 
upregulation and/or the supersensitization of cholinoreceptive 
neurons. The data we present support this. Our data are consistent 
with electrophysiological findings that ethanol enhances the 
excitatory response of hippocampal neurons to iontophoretically 
applied Ach (Mantillas et al, 1986). 
Treatment with ethanol upregulates mAchRs in rodents. Tabakoff et 
al (1979) observed that seven days of treatment with ethanol produced 
a 115% to 125% increase in the density of mAchRs radioligand binding 
sites in mouse brain. Smith (1973) gave ethanol, 7% by volume, to 
mice for 8 days and observed that this treatment produced severe 
dependence as evidenced by whole body tremor and convulsions upon 
routine handling. A cholinergically-enriched synaptosomal fraction 
from the brains of these animals showed a 28% increase in specific 
(QNB) binding. Rabin et al (1980) also found that this dose of 
ethanol increased the density of QNB binding sites in the hippocampus 
and cerebral cortex of mice. Very long term (75 weeks) treatment with 
ethanol (10%) produced a significant increase in mAchR radioligand 
binding sites which was detected 8 days following withdrawal (Nordberg 
and Wahlstrom, 1982). Upregulation of mAchRs persists for up to 4 
weeks following the withdrawal of ethanol. 
The enhanced responsiveness to oxotremorine observed in this study 
suggests that chronic ethanol treatment supersensitizes cholinoceptive 
neurons. Supersensitization of the muscarinic system is evident up 
to 96 hours following withdrawal of ethanol. The study was not 
designed to ascertain the decay of this phenomenon. This requires 
another study. Documentation that repeated challenges with 
oxotremorine, 0.25 mg/kg, did not produce carry-over effects supports 
the conclusion that chronic treatment with ethanol results in the 
supersensitization of cholinergic mechanisms. 
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Several commonly abused drugs inhibit the release of acetylcholine. 
These drugs include ethanol, barbiturates, opiates, and delta'- 
tetrahydrocannabinol. Pharmacological agents potently inhibiting the 
release of acetylcholine at muscarinic cholinergic junctions are 
expected to produce denervation supersensitivity of the post-synaptic 
neuron to acetylcholine and muscarinic agonists. This would likely 
be accompanied by the upregulation of post-synaptic muscarinic 
receptors. Investigators previously demonstrated that treatment with 
ethanol affects an increase in the density of treated guiniclidinyl- 
benzilate ([?i]QNB) binding sites. QNB is a ligand binding to 
muscarinic acetylcholine receptors. This study tested the hypothesis 
that chronic treatment with ethanol produces supersensitivity to 
muscarinic agonists. Seven days of treatment with ethanol (14% v:v 
in drinking water) was sufficient to enhance the thermic response to 
oxotremorine (0.25 mg/kg ip). The thermic response to oxotremorine 
remained elevated 96 hours following the conclusion of two weeks of 
treatment with ethanol. 
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